FDA inspection
Neopharm Labs Inc.: FDA inspection ending Feb 16, 2010
FDA inspection 661411 · Voluntary Action Indicated (VAI) · Blainville
Key facts
| Inspection ID | 661411 |
|---|---|
| Firm | Neopharm Labs Inc. |
| FEI number | 3002807703 |
| Address | 865 Michele-Bohec Blvd |
| City | Blainville |
| Country | Canada |
| Fiscal year | 2010 |
| Inspection end date | Feb 16, 2010 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data